Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
The summary for the Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional): The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for the continued development and sustainment of high-value informatics research resources to improve the acquisition, analysis, visualization, and interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on sustaining operations and improving the user experience and availability of existing, widely-adopted informatics tools and resources. This is in contrast to early-stage and advanced development efforts to generate these tools and resources that are supported by companion ITCR FOAs. To be successful, the proposed sustainment plan must provide clear justification for why the research resource should be maintained and how it has benefitted and will continue to benefit the cancer research field. In addition, mechanisms for assessing and maximizing the value of the resource to researchers and supporting collaboration and deep engagement between the resource and the targeted research community should be described.
Federal Grant Title: | Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Education Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-CA-23-017 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.393, 93.394, 93.395, 93.396, 93.399 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | November 17th, 2023 |
Original Application Deadline: | November 17th, 2023 |
Posted Date: | December 22nd, 2022 |
Creation Date: | December 22nd, 2022 |
Archive Date: | December 23rd, 2023 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | December 22nd, 2022 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
- Link to Full Grant Announcement
- https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-017.html
- Grant Announcement Contact
- NIH Grants Information
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
- • Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/...
- • Addressing the Primary Care Needs of Cancer Survivors (U01 Clinical Trial Required)
- • Early-Stage Development of Informatics Technologies for Cancer Research and Management (U0...
- • Advanced Development of Informatics Technologies for Cancer Research and Management (U24 C...
- • Pilot Studies in Pancreatic Cancer
- • Cancer Prevention Research Small Grant Program
- • Molecular Targets for Nutrients in Prostate Cancer Prevention
- More Grants from the National Institutes of Health
- • BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R...
- • Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorde...
- • BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R...
- • International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
- • Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IM...